Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2015; 21(42): 12071-12082
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12071
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12071
Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß, Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07740 Jena, Germany
Author contributions: Fahrner R, Settmacher U and Rauchfuß F designed the review; Fahrner R, Dondorf F, Ardelt M, Dittmar Y and Rauchfuß F performed the review; Fahrner R, Settmacher U and Rauchfuß F analyzed the data; Fahrner R and Rauchfuß F wrote the paper; Dondorf F, Ardelt M, Dittmar Y and Settmacher U revised the paper.
Conflict-of-interest statement: All authors have no conflicts of interest or financial ties to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Falk Rauchfuß, MD, MSc, Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07740 Jena, Germany. falk.rauchfuss@med.uni-jena.de
Telephone: +49-3641-9322601 Fax: +49-3641-9322602
Received: April 28, 2015
Peer-review started: May 5, 2015
First decision: July 13, 2015
Revised: August 4, 2015
Accepted: September 14, 2015
Article in press: September 14, 2015
Published online: November 14, 2015
Processing time: 197 Days and 10.6 Hours
Peer-review started: May 5, 2015
First decision: July 13, 2015
Revised: August 4, 2015
Accepted: September 14, 2015
Article in press: September 14, 2015
Published online: November 14, 2015
Processing time: 197 Days and 10.6 Hours
Core Tip
Core tip: Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide. Liver transplantation can be a curative treatment in selected patients. This review addresses the pre-, intra-, and postoperative factors that influence disease-free survival and the risk of tumor recurrence after liver transplantation. Furthermore, novel diagnostic methods are presented and discussed.